Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Massachusetts General Hospital
Patients who fulfill eligibility criteria will be randomized to Arm A or Arm B * Treatment will be administered on an outpatient basis. * Upon registration participants will be randomized to Arm A (FOLFIRINOX) or Arm B (Gemcitabine/nab-Paclitaxel). * After completion of FOLFIRINOX or Gemcitabine/Nab-paclitaxel, all participants without progressive disease will proceed to radiation therapy with capecitabine . * Between 2 and 4 weeks after radiation is complete, participants will proceed for surgical resection of pancreatic cancer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted